Clinical Trial Update: Subcutaneous Treprostinil as a Bridge to Lung Transplantation in Severe Pulmonary Hypertension: A Single-Arm Retrospective Study [Phase 4]

View source ↗

Summary

Phase 4 single-arm retrospective study assessing subcutaneous treprostinil as a bridge to lung transplantation in patients with severe pulmonary hypertension. T…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure
• Lung Disease-associated Pulmonary Hypertension
• Pulmonary Arterial Hypertension
• Pulmonary Hypertension

Drugs mentioned

• Remodulin (treprostinil)

Snippet

Sponsor: Guangzhou Institute of Respiratory Disease | Conditions: Pulmonary Hypertension, Pulmonary Arterial Hypertension | Phase 4 | Status: COMPLETED